ID CP11A_RABIT Reviewed; 445 AA. AC Q28827; DT 15-DEC-1998, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 08-NOV-2023, entry version 112. DE RecName: Full=Cholesterol side-chain cleavage enzyme, mitochondrial {ECO:0000303|PubMed:7682938}; DE EC=1.14.15.6 {ECO:0000250|UniProtKB:P05108}; DE AltName: Full=CYPXIA1; DE AltName: Full=Cholesterol desmolase; DE AltName: Full=Cytochrome P450 11A1; DE AltName: Full=Cytochrome P450(scc); DE Flags: Precursor; Fragment; GN Name=CYP11A1; OS Oryctolagus cuniculus (Rabbit). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus. OX NCBI_TaxID=9986; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=7682938; DOI=10.1210/endo.132.5.7682938; RA Yang X., Iwamoto K., Wang M., Artwohl J., Mason J.I., Pang S.; RT "Inherited congenital adrenal hyperplasia in the rabbit is caused by a RT deletion in the gene encoding cytochrome P450 cholesterol side-chain RT cleavage enzyme."; RL Endocrinology 132:1977-1982(1993). CC -!- FUNCTION: A cytochrome P450 monooxygenase that catalyzes the side-chain CC hydroxylation and cleavage of cholesterol to pregnenolone, the CC precursor of most steroid hormones. Catalyzes three sequential CC oxidation reactions of cholesterol, namely the hydroxylation at C22 CC followed with the hydroxylation at C20 to yield 20R,22R- CC hydroxycholesterol that is further cleaved between C20 and C22 to yield CC the C21-steroid pregnenolone and 4-methylpentanal. Mechanistically, CC uses molecular oxygen inserting one oxygen atom into a substrate and CC reducing the second into a water molecule. Two electrons are provided CC by NADPH via a two-protein mitochondrial transfer system comprising CC flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron- CC sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin). CC {ECO:0000250|UniProtKB:P05108}. CC -!- CATALYTIC ACTIVITY: CC Reaction=cholesterol + 6 H(+) + 3 O2 + 6 reduced [adrenodoxin] = 4- CC methylpentanal + 4 H2O + 6 oxidized [adrenodoxin] + pregnenolone; CC Xref=Rhea:RHEA:35739, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16113, ChEBI:CHEBI:16581, ChEBI:CHEBI:17998, CC ChEBI:CHEBI:33737, ChEBI:CHEBI:33738; EC=1.14.15.6; CC Evidence={ECO:0000250|UniProtKB:P05108}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35740; CC Evidence={ECO:0000250|UniProtKB:P05108}; CC -!- CATALYTIC ACTIVITY: CC Reaction=cholesterol + 2 H(+) + O2 + 2 reduced [adrenodoxin] = (22R)- CC hydroxycholesterol + H2O + 2 oxidized [adrenodoxin]; CC Xref=Rhea:RHEA:34335, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16113, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, CC ChEBI:CHEBI:67237; Evidence={ECO:0000250|UniProtKB:P05108}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34336; CC Evidence={ECO:0000250|UniProtKB:P05108}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(22R)-hydroxycholesterol + 2 H(+) + O2 + 2 reduced CC [adrenodoxin] = (20R,22R)-20,22-dihydroxycholesterol + H2O + 2 CC oxidized [adrenodoxin]; Xref=Rhea:RHEA:34339, Rhea:RHEA-COMP:9998, CC Rhea:RHEA-COMP:9999, ChEBI:CHEBI:1294, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:33737, CC ChEBI:CHEBI:33738, ChEBI:CHEBI:67237; CC Evidence={ECO:0000250|UniProtKB:P05108}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34340; CC Evidence={ECO:0000250|UniProtKB:P05108}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(20R,22R)-20,22-dihydroxycholesterol + 2 H(+) + O2 + 2 reduced CC [adrenodoxin] = 4-methylpentanal + 2 H2O + 2 oxidized [adrenodoxin] + CC pregnenolone; Xref=Rhea:RHEA:34343, Rhea:RHEA-COMP:9998, Rhea:RHEA- CC COMP:9999, ChEBI:CHEBI:1294, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:16581, ChEBI:CHEBI:17998, CC ChEBI:CHEBI:33737, ChEBI:CHEBI:33738; CC Evidence={ECO:0000250|UniProtKB:P05108}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34344; CC Evidence={ECO:0000250|UniProtKB:P05108}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; CC Evidence={ECO:0000250|UniProtKB:P05108}; CC -!- PATHWAY: Lipid metabolism; C21-steroid hormone metabolism. CC {ECO:0000250|UniProtKB:P05108}. CC -!- PATHWAY: Steroid metabolism; cholesterol metabolism. CC {ECO:0000250|UniProtKB:P05108}. CC -!- SUBUNIT: Interacts with FDX1/adrenodoxin. CC {ECO:0000250|UniProtKB:P05108}. CC -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane CC {ECO:0000250|UniProtKB:P14137}; Peripheral membrane protein CC {ECO:0000305}. Note=Localizes to the matrix side of the mitochondrion CC inner membrane. {ECO:0000250|UniProtKB:P14137}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; S59219; AAB26372.1; -; mRNA. DR PIR; A49189; A49189. DR AlphaFoldDB; Q28827; -. DR SMR; Q28827; -. DR STRING; 9986.ENSOCUP00000023976; -. DR PaxDb; 9986-ENSOCUP00000023976; -. DR eggNOG; KOG0159; Eukaryota. DR InParanoid; Q28827; -. DR UniPathway; UPA00229; -. DR UniPathway; UPA00296; -. DR Proteomes; UP000001811; Unplaced. DR GO; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB. DR GO; GO:0008386; F:cholesterol monooxygenase (side-chain-cleaving) activity; ISS:UniProtKB. DR GO; GO:0020037; F:heme binding; ISS:UniProtKB. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0006700; P:C21-steroid hormone biosynthetic process; ISS:UniProtKB. DR GO; GO:0008203; P:cholesterol metabolic process; ISS:UniProtKB. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR002399; Cyt_P450_mitochondrial. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24279; -; 1. DR PANTHER; PTHR24279:SF3; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME, MITOCHONDRIAL; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00408; MITP450. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. PE 2: Evidence at transcript level; KW Cholesterol metabolism; Heme; Iron; Lipid metabolism; Membrane; KW Metal-binding; Mitochondrion; Mitochondrion inner membrane; Monooxygenase; KW Oxidoreductase; Reference proteome; Steroid metabolism; Steroidogenesis; KW Sterol metabolism; Transit peptide. FT TRANSIT <1..36 FT /note="Mitochondrion" FT /evidence="ECO:0000250|UniProtKB:P00189" FT CHAIN 37..>445 FT /note="Cholesterol side-chain cleavage enzyme, FT mitochondrial" FT /id="PRO_0000003589" FT NON_TER 1 FT NON_TER 445 SQ SEQUENCE 445 AA; 51016 MW; B6080DFFB028C8CA CRC64; RGLPSRSVFL RGCQASLSTA QERLGHPGVP TREGVRVATR SPRPYHEIPS PGDNGWLNLY HLAEEKGTHR VHYRHVQNFQ KYGPIYRENL GNVESVYIMD PEDVALLFNS EGPQPERFLI PPWVAYHEYY RRPVGVLLKK AQGWKRDRVA LNQEVMAPDA IKNFVPLLEA VSQAFVRMLH GRVQQGVFSG DISDDLFRFA FESMTNIMFG ERLGMLEETV DPEAHEFIDA VYQMFHTSVP MLSLPPSLFR LFRTRTWRDH VAAWDVIFTN ADKYTQSFYW DLRQKQDLGG SYRGILYSLL GTSKLSFEDI KANVTEMLAG SVDTTSMTLQ WHLYEMGAAL GMQEMLRAEV LAARRQAQGD MTAMLQSVPL LKASIKETLR LHPISVTLQR YLVNDLVLQD YMIPAKTLVQ VANYGMGREP SFFANPEKFD PPRWLDKDKN ATHFR //